INDICATION TEPMETKO is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping …

Tepotinib (Tepmetko®) has info patients should know about. Read, listen, and watch videos about side effects from Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancer (NSCLC)

TEPMETKO is a kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping …

Compare prices and print coupons for Tepmetko and other drugs at CVS, Walgreens, and other pharmacies. Prices start at $25,366.14

Product related information contained herein is subject to local approval and can therefore vary from country. It may refer to a product or indications not yet registered or approved in a given country. For …

INDICATION What is TEPMETKO used for? TEPMETKO® (tepotinib) is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that: has spread to other parts of the body …

Apr 21, 2025 · Find patient medical information for Tepmetko (tepotinib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings